$IVDA
Iveda Solutions, Inc. Stock $ivda

$ivda Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017431 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$2.392M	$2.205M	$230.9K
YoY Change	267.17%	855.2%
Cost Of Revenue	$2.111M	$1.718M	$90.31K
YoY Change	356.33%	1802.88%
Gross Profit	$281.1K	$486.7K	$140.6K
YoY Change	48.84%	246.26%
Gross Profit Margin	11.75%	22.07%	60.88%
Selling, General & Admin	$1.101M	$1.038M	$792.2K
YoY Change	-11.68%	30.99%
% of Gross Profit	391.75%	213.21%	563.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.160K	$5.030K	$4.660K
YoY Change	-49.77%	7.94%
% of Gross Profit	0.77%	1.03%	3.32%
Operating Expenses	$1.101M	$1.038M	$792.2K
YoY Change	-11.68%	30.99%
Operating Profit	-$820.3K	-$551.0K	-$651.6K
YoY Change	-22.49%	-15.45%
Interest Expense	$3.028K	$517.00	-$12.21K
YoY Change	-77.54%	-104.23%
% of Operating Profit
Other Income/Expense, Net	$2.798K	$19.40K	$170.00
YoY Change	-141.21%	11310.59%
Pretax Income	-$757.5K	-$531.6K	-$663.7K
YoY Change	-28.87%	-19.9%
Income Tax	-$113.00	$18.70K	$3.140K
% Of Pretax Income
Net Earnings	-$757.4K	-$550.3K	-$666.8K
YoY Change	-28.88%	-17.48%
Net Earnings / Revenue	-31.67%	-24.95%	-288.83%
Basic Earnings Per Share	-$0.05	-$0.04	-$0.07
Diluted Earnings Per Share	-$0.05	-$0.04	-$68.94K
COMMON SHARES
Basic Shares Outstanding	16.01M shares	16.01M shares	9.673M shares
Diluted Shares Outstanding	15.94M shares	15.29M shares	9.673M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.601M	$8.380M	$746.9K
YoY Change	38.79%	1021.91%
Cash & Equivalents	$8.601M	$8.380M	$746.9K
Short-Term Investments
Other Short-Term Assets	$232.0K	$162.5K	$324.5K
YoY Change	-5.14%	-49.93%
Inventory	$305.2K	$388.2K	$576.2K
Prepaid Expenses
Receivables	$236.9K	$505.6K	$146.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.503M	$9.566M	$1.794M
YoY Change	29.67%	433.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$465.2K	$204.5K	$37.71K
YoY Change	1391.25%	442.34%
Goodwill
YoY Change
Intangibles			$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$270.7K	$288.6K	$256.6K
YoY Change	16.53%	12.49%
Total Long-Term Assets	$735.9K	$493.1K	$294.3K
YoY Change	179.27%	67.58%
TOTAL ASSETS
Total Short-Term Assets	$9.503M	$9.566M	$1.794M
Total Long-Term Assets	$735.9K	$493.1K	$294.3K
Total Assets	$10.24M	$10.06M	$2.089M
YoY Change	34.87%	381.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.462M	$478.1K	$2.992M
YoY Change	289.15%	-84.02%
Accrued Expenses	$844.6K	$789.2K
YoY Change	-47.07%
Deferred Revenue
YoY Change
Short-Term Debt	$289.1K	$163.7K	$224.7K
YoY Change	32.45%	-27.11%
Long-Term Debt Due		$65.50K	$116.4K
YoY Change		-43.74%
Total Short-Term Liabilities	$2.698M	$1.543M	$3.633M
YoY Change	-2.28%	-57.54%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$174.7K	$298.8K
YoY Change	-100.0%	-41.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$174.7K	$298.8K
YoY Change	-100.0%	-41.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.698M	$1.543M	$3.633M
Total Long-Term Liabilities	$0.00	$174.7K	$298.8K
Total Liabilities	$2.638M	$1.717M	$3.932M
YoY Change	-12.68%	-56.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.01M	-$45.26M
YoY Change	6.78%
Common Stock	$160.00	$159.00
YoY Change	36.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.541M	$8.342M	-$1.843M
YoY Change
Total Liabilities & Shareholders Equity	$10.24M	$10.06M	$2.089M
YoY Change	34.87%	381.63%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$757.4K	-$550.3K	-$666.8K
YoY Change	-28.88%	-17.48%
Depreciation, Depletion And Amortization	$2.160K	$5.030K	$4.660K
YoY Change	-49.77%	7.94%
Cash From Operating Activities	$678.6K	$172.6K	-$770.2K
YoY Change	-148.03%	-122.4%
INVESTING ACTIVITIES
Capital Expenditures	$263.5K	$176.2K	-$4.700K
YoY Change	9518.61%	-3848.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$263.5K	-$176.2K	-$4.700K
YoY Change	-9718.61%	3648.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-131.9K	$1.072M	145.5K
YoY Change	-101.91%	636.59%
NET CHANGE
Cash From Operating Activities	678.6K	$172.6K	-770.2K
Cash From Investing Activities	-263.5K	-$176.2K	-4.700K
Cash From Financing Activities	-131.9K	$1.072M	145.5K
Net Change In Cash	283.2K	$1.068M	-629.4K
YoY Change	-94.85%	-269.65%
FREE CASH FLOW
Cash From Operating Activities	$678.6K	$172.6K	-$770.2K
Capital Expenditures	$263.5K	$176.2K	-$4.700K
Free Cash Flow	$415.0K	-$3.593K	-$765.5K
YoY Change	-129.32%	-99.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001397183
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q4	IVDA	Long Term Dividend Payable LongTermDividendPayable		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
CY2022Q1	IVDA	Proceeds From Repayments Of Changes In Restricted Cash ProceedsFromRepaymentsOfChangesInRestrictedCash		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2023Q1	IVDA	Payments For Proceeds From Financing And Stock Issuance Costs PaymentsForProceedsFromFinancingAndStockIssuanceCosts		usd
CY2022Q1	IVDA	Payments For Proceeds From Financing And Stock Issuance Costs PaymentsForProceedsFromFinancingAndStockIssuanceCosts		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	IVDA	Dividends Paid With Series B Preferred Stock DividendsPaidWithSeriesBPreferredStock		usd
CY2023Q1	IVDA	Warrants Issued For Interest WarrantsIssuedForInterest		usd
CY2023Q1	IVDA	Warrants Issued For Services WarrantsIssuedForServices		usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-53285
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	IVEDA SOLUTIONS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2222203
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1744 S Val Vista
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 213
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Mesa
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85204
CY2023Q1	dei	City Area Code CityAreaCode	(480)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	307-8700
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16012639	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8379854	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7312095	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	129702	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	129527	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	505581	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1222690	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	388246	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	526470	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	162469	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	371990	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9565852	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9562772	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204516	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32911	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	288599	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	267387	usd
CY2023Q1	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	288599	usd
CY2022Q4	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	267387	usd
CY2023Q1	us-gaap	Assets Assets	10058967	usd
CY2022Q4	us-gaap	Assets Assets	9863070	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1313360	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1638727	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	163747	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	398409	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	65498	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	65408	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1542605	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2102544	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	174664	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	190776	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16012639	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16012639	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15066739	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15066739	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	159	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	150	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53819790	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52496914	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-221317	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-220643	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45256934	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44706671	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8341698	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7569750	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10058967	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9863070	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2205164	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230857	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1718492	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	90310	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	486673	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	140547	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1037631	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	792164	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1037631	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	792164	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-550958	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-651616	usd
CY2023Q1	IVDA	Miscellaneous Income Expense MiscellaneousIncomeExpense	53	usd
CY2022Q1	IVDA	Miscellaneous Income Expense MiscellaneousIncomeExpense	172	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	19862	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	616	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	517	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	12833	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19398	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12045	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-531561	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-663662	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18702	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3136	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-550263	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-666798	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15489689	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9672508	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-777279	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	-1163918	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	120581	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	219900	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5555	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8011250	usd
CY2022	IVDA	Common Stock And Prefunded Warrant Offering CommonStockAndPrefundedWarrantOffering	4999836	usd
CY2022	IVDA	Adjustments To Additional Paid In Capital Warrants Sold In Over Allotment AdjustmentsToAdditionalPaidInCapitalWarrantsSoldInOverAllotment	2797	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3345270	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-77150	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7569750	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7569750	usd
CY2023Q1	IVDA	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	1322885	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-550263	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-674	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8341698	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8341698	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-8
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-550263	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-666798	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5030	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4657	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	67500	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-717109	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-330272	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-138223	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	242576	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-209521	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-31085	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	21347	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-8302	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-325710	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-302666	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	172563	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-770224	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	176156	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4696	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-176156	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4696	usd
CY2023Q1	IVDA	Proceeds From Repayments Of Changes In Restricted Cash ProceedsFromRepaymentsOfChangesInRestrictedCash	-175	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-234572	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	174648	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-16112	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-29108	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1322885	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1072026	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	145540	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-674	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-8964	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1067759	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-638344	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7312095	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1385275	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8379854	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	746931	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	517	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	330	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1634	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	1895000	usd
CY2022Q1	IVDA	Dividends Paid With Series B Preferred Stock DividendsPaidWithSeriesBPreferredStock	23750	usd
CY2022Q1	IVDA	Warrants Issued For Interest WarrantsIssuedForInterest	139458	usd
CY2022Q1	IVDA	Warrants Issued For Services WarrantsIssuedForServices	11475	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_z5nQSFbyDkKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_865_zUsgOlr0WQed">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zIGNrXqaX4Zh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86A_zZ5g0WH4MRBe">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit Insurance Corporation) with maximum coverage of NTD 3 million. At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers’ financial condition and generally do not require collateral. At December 31, 2022 one customer out of a total of 36 customer accounts receivable accounts was <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ChunghwaTelecomMember_zyi6UvDTuRs1" title="Concentration risk, percentage">52%</span> of the total accounts receivable. This specific customer was Chicony Power Technology Co Ltd. One customer (Chunghwa Telecom) represented approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zGLf2FDXv661" title="Percentage of concentration risk">95%</span> of total accounts receivable of $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_c20211231__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zM9IhO23m5pf" title="Account receivable">492,752</span> as of December 31, 2021. These customers are longtime customers, and we don’t expect any problem with collectability of these accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from two customers out of 42 total customers represented approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zvi2FDOcXqHb" title="Concentration risk, percentage">52%</span> of total revenue for the year ended December 31, 2022. These specific customers were 1) We had $<span id="xdx_90E_eus-gaap--Revenues_pdp0_c20220101__20221231__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zgopPCW308G8" title="Revenues">948,592</span> revenues (<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zAPJQargLvsg" title="Concentration risk, percentage">21%</span>) from Chunghwa Telecom, 2) We had $<span id="xdx_901_eus-gaap--Revenues_c20220101__20221231__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyCoLtdMember_zU5mvUy04uP2" title="Revenues">1,385,026</span> revenues (<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChiconyPowerTechnologyMember_zRVykYLynjIk" title="Concentration risk, percentage">31%</span>) from Chicony Power Technology Co Ltd, (both Taiwan companies) of total revenues of $<span id="xdx_904_eus-gaap--Revenues_c20220101__20221231_zQWxlfyhiS54" title="Revenues">4,468,279</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had revenue from two customers with greater than <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember__srt--RangeAxis__srt--MinimumMember_zDLta1mnsLG8">10%</span> of total revenues for the year ended December 31, 2021 that represented approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zGzvi9m2vHb9" title="Concentration risk, percentage">55%</span> of total revenues. We had $<span id="xdx_90D_eus-gaap--Revenues_c20210101__20211231__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zRoSngqtQRub" title="Revenues">786,686</span> revenues (<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--ChunghwaTelecomMember_zLzF5aXmcTb7" title="Concentration risk, percentage">41%</span>) from Chunghwa Telecom and $<span id="xdx_902_eus-gaap--Revenues_c20210101__20211231__dei--LegalEntityAxis__custom--TaiwanStockExchangeCorporationMember_z5ekF7twuGV4" title="Revenues">260,946</span> revenues (<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__dei--LegalEntityAxis__custom--TaiwanStockExchangeCorporationMember_ziv3joIrn7p1" title="Concentration risk, percentage">14%</span>) from Taiwan Stock Exchange Corporation of total revenues of $<span id="xdx_90F_eus-gaap--Revenues_c20210101__20211231_zmn9Km4nPvE3" title="Revenues">1,917,848</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No other customers represented greater than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_zymiVrcPqSog" title="Percentage of concentration risk"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OtherCustomersMember__srt--RangeAxis__srt--MinimumMember_ziZF6VAR2Z8h" title="Percentage of concentration risk">10%</span></span> of total revenues in years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Revenues Revenues	4468279	usd
CY2021	us-gaap	Revenues Revenues	1917848	usd
CY2022Q4	IVDA	Uncollectible Accounts UncollectibleAccounts	0	usd
CY2021Q4	IVDA	Uncollectible Accounts UncollectibleAccounts	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022	us-gaap	Depreciation Depreciation	17801	usd
CY2021	us-gaap	Depreciation Depreciation	15016	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	478117	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	360395	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	789194	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1243027	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	46050	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	35305	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1313360	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1638727	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	120581	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	801908	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zPg5iFP7lPX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zbJ45bmxioej">Reclassification</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in 2022 have been reclassified to conform to the 2023 presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	163747	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	398409	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	65498	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	65408	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	174664	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	190776	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	93887	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	10800000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10800000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9800000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1000000	usd
CY2021	IVDA	Year Of Expiration YearOfExpiration	2041
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	590000	usd
CY2020	IVDA	Year Of Expiration YearOfExpiration	2040
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	260000	usd
CY2019	IVDA	Year Of Expiration YearOfExpiration	2039
CY2018Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	160000	usd
CY2018	IVDA	Year Of Expiration YearOfExpiration	2038
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	140000	usd
CY2017	IVDA	Year Of Expiration YearOfExpiration	2037
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1640000	usd
CY2016	IVDA	Year Of Expiration YearOfExpiration	2036
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3400000	usd
CY2015	IVDA	Year Of Expiration YearOfExpiration	2035
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5230000	usd
CY2014	IVDA	Year Of Expiration YearOfExpiration	2034
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5600000	usd
CY2013	IVDA	Year Of Expiration YearOfExpiration	2033
CY2012Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2850000	usd
CY2012	IVDA	Year Of Expiration YearOfExpiration	2032
CY2011Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2427000	usd
CY2011	IVDA	Year Of Expiration YearOfExpiration	2031
CY2010Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1799000	usd
CY2010	IVDA	Year Of Expiration YearOfExpiration	2030
CY2009Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1750000	usd
CY2009	IVDA	Year Of Expiration YearOfExpiration	2029
CY2008Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1308000	usd
CY2008	IVDA	Year Of Expiration YearOfExpiration	2028
CY2007Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	429000	usd
CY2007	IVDA	Year Of Expiration YearOfExpiration	2027
CY2006Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	476000	usd
CY2006	IVDA	Year Of Expiration YearOfExpiration	2026
CY2005Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	414000	usd
CY2005	IVDA	Year Of Expiration YearOfExpiration	2025
CY2023Q1	IVDA	Taiwan Corporate Tax Rate TaiwanCorporateTaxRate	Sole-Vision Technologies, Inc. is a subsidiary of the Company which is operating in Taiwan as a profit-seeking enterprise. Its applicable corporate income tax rate is 17%. In addition, Taiwan’s corporate tax system allows the government to levy a 10% profit retention tax on undistributed earnings for the prior year. This tax will not be provided if the company distributed the earnings before the ended of the fiscal year
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-550263	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-666798	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15289689	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9672508	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07

Files In Submission

Name	View Source	Status
ivda-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ivda-20230331_pre.xml	Edgar Link	unprocessable
0001493152-23-017431-index-headers.html	Edgar Link	pending
0001493152-23-017431-index.html	Edgar Link	pending
0001493152-23-017431.txt	Edgar Link	pending
0001493152-23-017431-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ivda-20230331.xsd	Edgar Link	pending
ivda-20230331_def.xml	Edgar Link	unprocessable
ivda-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVDA
Iveda Solutions, Inc. Stock $ivda

2023 Q2 Form 10-Q Financial Statement

#000149315223017431 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDA Iveda Solutions, Inc. Stock $ivda

2023 Q2 Form 10-Q Financial Statement

#000149315223017431 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDA
Iveda Solutions, Inc. Stock $ivda